Your browser doesn't support javascript.
loading
Systemic Lupus Erythematosus and Cytokine Storm.
Caricchio, Roberto; Gallucci, Stefania.
Afiliación
  • Caricchio R; UMass Chan Medical School, Worcester, MA, USA. Lupus.Caricchio@umassmed.edu.
  • Gallucci S; UMass Chan Medical School, Worcester, MA, USA.
Adv Exp Med Biol ; 1448: 355-364, 2024.
Article en En | MEDLINE | ID: mdl-39117826
ABSTRACT
Systemic lupus erythematosus (SLE) is the prototype of autoimmune diseases and can manifest with a plethora of clinical signs and symptoms associated with a myriad of laboratory abnormalities. An infrequent but potentially lethal complication of SLE is macrophage activation syndrome (MAS). The diagnosis of MAS in SLE can be very challenging due to similarities in presentation of both flares and infections, such as fever, lymphadenopathy, splenomegaly, and cytopenias. These aggravating factors contribute to the increased risk of poor outcomes in SLE-associated MAS. Indeed, at the moment MAS remains invariably lethal if untreated and still has a high mortality rate with treatment. In this chapter, we discuss several aspects of MAS in the context of SLE and in particular, the pathogenesis of MAS in SLE, how MAS presents in pediatric versus adult SLE, and, finally, MAS treatment in SLE and future directions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Activación Macrofágica / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Adv Exp Med Biol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Activación Macrofágica / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Adv Exp Med Biol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos